BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

521 related articles for article (PubMed ID: 30535191)

  • 41. Does surgery improve survival of patients with malignant pleural mesothelioma?: a multicenter retrospective analysis of 1365 consecutive patients.
    Bovolato P; Casadio C; Billè A; Ardissone F; Santambrogio L; Ratto GB; Garofalo G; Bedini AV; Garassino M; Porcu L; Torri V; Pastorino U
    J Thorac Oncol; 2014 Mar; 9(3):390-6. PubMed ID: 24518090
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma.
    Weder W; Stahel RA; Bernhard J; Bodis S; Vogt P; Ballabeni P; Lardinois D; Betticher D; Schmid R; Stupp R; Ris HB; Jermann M; Mingrone W; Roth AD; Spiliopoulos A;
    Ann Oncol; 2007 Jul; 18(7):1196-202. PubMed ID: 17429100
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intensity modulated radiation therapy after extra-pleural pneumonectomy for malignant pleural mesothelioma is feasible without fatal pulmonary toxicity and provides good survival.
    Jhavar S; Pruszynski J; Gowan A; Boyle T; Deb N; Patel M
    Asia Pac J Clin Oncol; 2018 Apr; 14(2):e88-e94. PubMed ID: 28371288
    [TBL] [Abstract][Full Text] [Related]  

  • 44. How does the timing of chemotherapy affect outcome following radical surgery for malignant pleural mesothelioma?
    Sharkey AJ; O'Byrne KJ; Nakas A; Tenconi S; Fennell DA; Waller DA
    Lung Cancer; 2016 Oct; 100():5-13. PubMed ID: 27597274
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Extrapleural pneumonectomy for malignant mesothelioma: an Italian multicenter retrospective study.
    Spaggiari L; Marulli G; Bovolato P; Alloisio M; Pagan V; Oliaro A; Ratto GB; Facciolo F; Sacco R; Brambilla D; Maisonneuve P; Mucilli F; Alessandrini G; Leoncini G; Ruffini E; Fontana P; Infante M; Pariscenti GL; Casiraghi M; Rea F
    Ann Thorac Surg; 2014 Jun; 97(6):1859-65. PubMed ID: 24726598
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Trimodality management of malignant pleural mesothelioma.
    Maggi G; Casadio C; Cianci R; Rena O; Ruffini E
    Eur J Cardiothorac Surg; 2001 Mar; 19(3):346-50. PubMed ID: 11251277
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Early-stage Clinical Characterization of Malignant Pleural Mesothelioma.
    Negi Y; Kuribayashi K; Funaguchi N; Doi H; Mikami K; Minami T; Takuwa T; Yokoi T; Hasegawa S; Kijima T
    In Vivo; 2018; 32(5):1169-1174. PubMed ID: 30150440
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Induction chemotherapy, extrapleural pneumonectomy and adjuvant radiotherapy for malignant pleural mesothelioma.
    Casiraghi M; Maisonneuve P; Brambilla D; Solli P; Galetta D; Petrella F; Piperno G; De Marinis F; Spaggiari L
    Eur J Cardiothorac Surg; 2017 Nov; 52(5):975-981. PubMed ID: 28482086
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Trimodality therapy for malignant pleural mesothelioma: results from an EORTC phase II multicentre trial.
    Van Schil PE; Baas P; Gaafar R; Maat AP; Van de Pol M; Hasan B; Klomp HM; Abdelrahman AM; Welch J; van Meerbeeck JP;
    Eur Respir J; 2010 Dec; 36(6):1362-9. PubMed ID: 20525721
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pleurectomy/decortication, hyperthermic pleural lavage with povidone-iodine, prophylactic radiotherapy, and systemic chemotherapy in patients with malignant pleural mesothelioma: a 10-year experience.
    Lang-Lazdunski L; Bille A; Papa S; Marshall S; Lal R; Galeone C; Landau D; Steele J; Spicer J
    J Thorac Cardiovasc Surg; 2015 Feb; 149(2):558-65; discussion 565-6. PubMed ID: 25726878
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Disparities in Compliance With National Guidelines for the Treatment of Malignant Pleural Mesothelioma.
    Espinoza-Mercado F; Borgella JD; Berz D; Alban RF; Sarkissian A; Imai HTA; Soukiasian HJ
    Ann Thorac Surg; 2019 Sep; 108(3):889-896. PubMed ID: 31004585
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Updated meta-analysis of survival after extrapleural pneumonectomy versus pleurectomy/decortication in mesothelioma.
    Magouliotis DE; Tasiopoulou VS; Athanassiadi K
    Gen Thorac Cardiovasc Surg; 2019 Mar; 67(3):312-320. PubMed ID: 30374811
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Current surgical strategies for malignant pleural mesothelioma.
    Takuwa T; Hasegawa S
    Surg Today; 2016 Aug; 46(8):887-94. PubMed ID: 26590581
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Preoperative concurrent chemoradiotherapy followed by extrapleural pneumonectomy for patients with non-small cell lung cancer with malignant pleural effusion and/or pleural nodules: Ten-year results of a prematurely terminated single institute phase II trial.
    Yamaguchi M; Ichinose Y; Shimamatsu S; Yoshida T; Toyokawa G; Nosaki K; Hirai F; Seto T; Takenoyama M
    Surg Oncol; 2015 Jun; 24(2):78-83. PubMed ID: 25818753
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Extrapleural Pneumonectomy Versus Pleurectomy/Decortication for Malignant Pleural Mesothelioma.
    Zhou N; Rice DC; Tsao AS; Lee PP; Haymaker CL; Corsini EM; Antonoff MB; Hofstetter WL; Rajaram R; Roth JA; Swisher SG; Vaporciyan AA; Walsh GL; Mehran RJ; Sepesi B
    Ann Thorac Surg; 2022 Jan; 113(1):200-208. PubMed ID: 33971174
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Extrapleural pneumonectomy for malignant pleural mesothelioma].
    Hosokawa Y; Matsuge S; Hayashi K; Kawahara Y; Ishigooka M; Kan T; Yamaawa T; Hatakeyama H; Murakami Y
    Kyobu Geka; 2004 Oct; 57(11):1018-22. PubMed ID: 15510814
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Propensity matched comparison of extrapleural pneumonectomy and pleurectomy/decortication for mesothelioma patients.
    Kostron A; Friess M; Inci I; Hillinger S; Schneiter D; Gelpke H; Stahel R; Seifert B; Weder W; Opitz I
    Interact Cardiovasc Thorac Surg; 2017 May; 24(5):740-746. PubMed ID: 28453802
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The mTOR Signaling Pathway Is Associated With the Prognosis of Malignant Pleural Mesothelioma After Multimodality Therapy.
    Kuroda A; Matsumoto S; Fukuda A; Nakamichi T; Nakamura A; Hashimoto M; Takuwa T; Kondo N; Tsujimura T; Nakano T; Hasegawa S
    Anticancer Res; 2019 Nov; 39(11):6241-6247. PubMed ID: 31704853
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Specimen weight and volume: important predictors of survival in malignant pleural mesothelioma.
    Kircheva DY; Husain AN; Watson S; Kindler HL; Durkin A; Vigneswaran WT
    Eur J Cardiothorac Surg; 2016 Jun; 49(6):1642-7. PubMed ID: 26802143
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Current Treatment of Mesothelioma: Extrapleural Pneumonectomy Versus Pleurectomy/Decortication.
    Wolf AS; Flores RM
    Thorac Surg Clin; 2016 Aug; 26(3):359-75. PubMed ID: 27427530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.